Cargando…
The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling
Chemotherapy resistant prostate cancer is a major clinical problem. When the prostate cancer has become androgen deprivation resistant, one of the few treatment regimens left is chemotherapy. There is a strong connection between a cancer’s stem cell like characteristics and drug resistance. By perfo...
Autores principales: | Faria, Michelle, Shepherd, Peter, Pan, Yinghong, Chatterjee, Sujash S., Navone, Nora, Gustafsson, Jan-Åke, Strom, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284737/ https://www.ncbi.nlm.nih.gov/pubmed/30555629 http://dx.doi.org/10.18632/oncotarget.26345 |
Ejemplares similares
-
The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling
por: Faria, Michelle, et al.
Publicado: (2018) -
Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer
por: Dey, Prasenjit, et al.
Publicado: (2015) -
Correction: Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer
por: Dey, Prasenjit, et al.
Publicado: (2015) -
Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces Cancer Stem Cells in Triple Negative Breast Cancer
por: Bano, Ayesha, et al.
Publicado: (2023) -
Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
por: Chaurasiya, Surendra, et al.
Publicado: (2020)